The last 20 actions on file set price targets from $94.00 to $157.00, averaging $116.35.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 30 Sep 2026 | Barclays | BUY | $157.00 |
| 24 Sep 2026 | TD Cowen | BUY | $110.00 |
| 14 Sep 2026 | Evercore | BUY | $130.00 |
| 10 Sep 2026 | H.C. Wainwright | BUY | $120.00 |
| 2 Sep 2026 | H.C. Wainwright | BUY | $120.00 |
| 31 Aug 2026 | Mizuho Securities | BUY | $110.00 |
| 31 Aug 2026 | Piper Sandler | BUY | $115.00 |
| 31 Aug 2026 | Jefferies | BUY | $110.00 |
| 31 Aug 2026 | Barclays | BUY | $157.00 |
| 29 Aug 2026 | Cantor Fitzgerald | BUY | $110.00 |
| 14 Aug 2026 | RBC Capital | BUY | $100.00 |
| 12 Aug 2026 | CCORF | BUY | $106.00 |
| 12 Aug 2026 | Truist Financial | BUY | $107.00 |
| 12 Aug 2026 | Citi | HOLD | $94.00 |
| 12 Aug 2026 | Barclays | BUY | $157.00 |
| 12 Aug 2026 | J.P. Morgan | BUY | $111.00 |
| 11 Aug 2026 | TD Cowen | BUY | $110.00 |
| 11 Aug 2026 | Wells Fargo | BUY | $102.00 |
| 11 Aug 2026 | BofA Securities | BUY | $104.00 |
| 11 Aug 2026 | Morgan Stanley | BUY | $97.00 |
No comments yet — be the first to weigh in on BBIO.